Differences in the sensitizing capacity of neomycin in creams and in ointments.
D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity; D004349:Drug Packaging; D006801:Humans; D009355:Neomycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000633:toxicity; D009824:Ointments; D011208:Powders; D012882:Skin Tests; D012996:Solutions
D009824:Ointments; D011208:Powders; D012996:Solutions; D009355:Neomycin